Home
|
Contact Us
|
Sitemap
Overview
Management Team
Board of Directors
Scientific Advisory Board
Careers
Current Openings
Benefits
About Pathogen Inactivation
Conventional Blood Testing
International Consensus Conference on Pathogen Inactivation
Glossary of Terms
How INTERCEPT Works
Product Pipeline
Commercializing The INTERCEPT System
The INTERCEPT Blood System
Case Study
Abstracts
Archived Abstracts
Publications
Archived Publications
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
Global Links
Management Team
Investors
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
Investor Overview
Corporate Governance
Analyst Coverage
Press Releases
Investor Events
Webcasts
Annual Reports
Annual Meeting
Stock Information
SEC Filings
Information Request
Investor Contacts
RSS Feeds
Press Releases
Normal
Press Release RSS
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Date
Subject
February 2, 2012
February 2, 2012
Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012
February 1, 2012
February 1, 2012
Cerus and Ilex BioTech Report INTERCEPT Platelet and Plasma System Approvals in Israel
January 9, 2012
January 9, 2012
Cerus Appoints Andrew Gomperts as Chief Business Officer
© 2012 Cerus Corporation
Legal
|
Privacy
Powered By Q4 Web Systems
3.5.18.3156